title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Treating Geographic Atrophy Remains a Tough Call for Ophthalmologists as They Voice Hesitancy to Prescribe Complement Inhibitors,20240627T124955,https://www.benzinga.com/pressreleases/24/06/g39524015/treating-geographic-atrophy-remains-a-tough-call-for-ophthalmologists-as-they-voice-hesitancy-to-p,BLTE,0.045396,Somewhat-Bullish,0.21708
"Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday",20220705T083503,https://www.benzinga.com/news/22/07/27948361/accolade-shares-jump-around-29-heres-75-biggest-movers-from-friday,BLTE,0.061758,Neutral,0.020428
70 Biggest Movers From Friday,20220502T094646,https://www.benzinga.com/news/22/05/26923653/70-biggest-movers-from-friday,BLTE,0.078844,Neutral,0.003429
"The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs",20220503T130106,https://www.benzinga.com/general/biotech/22/05/26958446/the-daily-biotech-pulse-fdas-adcomm-for-acadias-pimavanserin-review-issues-for-speros-tebipenem-a,BLTE,0.093507,Neutral,0.059115
The Benchmark Company Announces Upcoming 12th Annual Discovery One-on-One Investor Conference,20231110T144754,https://www.benzinga.com/pressreleases/23/11/g35726156/the-benchmark-company-announces-upcoming-12th-annual-discovery-one-on-one-investor-conference,BLTE,0.069094,Neutral,0.0
"Why LL Flooring Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket - AcelRx Pharmaceuticals  ( NASDAQ:ACRX ) , Aclarion  ( NASDAQ:ACON ) ",20230531T123927,https://www.benzinga.com/news/23/05/32645917/why-ll-flooring-shares-are-trading-higher-by-19-here-are-20-stocks-moving-premarket,BLTE,0.151539,Neutral,-0.037473
